-- Kelun Group faces intense competition that may prevent it from
maintaining or increasing market share for its existing products and
gaining market acceptance for Kelun Group's future products.
-- Kelun Group's competitors may develop or commercialize products before
Kelun Group or more successfully than Kelun Group can.
-- Pharmaceutical companies in the PRC require a number of permits and
licenses in order to carry on their business.
-- Kelun Group is substantially dependent on generic electrolyte and acid-
base balancing solutions and its profitability would be materially and
adversely affected if sales of these products were to decline.
|SOURCE Shanghai Century Acquisition Corporation|
Copyright©2007 PR Newswire.
All rights reserved